Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU7-113P is a pseudogene related to the U7 small nuclear RNA (U7 snRNA). U7 snRNA is a component of the U7 small nuclear ribonucleoprotein (snRNP) complex and is essential for processing histone pre-mRNAs in eukaryotic cells, influencing chromatin structure and DNA replication in cell division[3][1][4]. Pseudogenes like RNU7-113P typically arise when a functional gene is duplicated or mutated and loses its capacity to express a functional product. While some pseudogenes have regulatory roles in disease by acting as miRNA sponges or affecting gene expression[2], there is no evidence that RNU7-113P is functional or relevant as a direct drug target or biomarker. It should not be classified as a receptor, enzyme, transporter, or transcription factor.
None reported. No drugs act on RNU7-113P.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U7 small nuclear RNA 113 pseudogene (RNU7-113P).